Blum RA - Search Results

1

Effect of fluconazole on the disposition of phenytoin.

Blum RA, Wilton JH, Hilligoss DM, Gardner MJ, Henry EB, Harrison NJ, Schentag JJ. Blum RA, et al. Clin Pharmacol Ther. 1991 Apr;49(4):420-5. doi: 10.1038/clpt.1991.49. Clin Pharmacol Ther. 1991. PMID: 2015731 Clinical Trial.

2

Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.

Blum RA, Kohli RK, Harrison NJ, Schentag JJ. Blum RA, et al. Antimicrob Agents Chemother. 1989 Sep;33(9):1470-6. doi: 10.1128/AAC.33.9.1470. Antimicrob Agents Chemother. 1989. PMID: 2817847 Free PMC article.

3

The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.

Blum RA, Schentag JJ, Gardner MJ, Wilner KD. Blum RA, et al. Br J Clin Pharmacol. 1995;39 Suppl 1(Suppl 1):35S-38S. doi: 10.1111/j.1365-2125.1995.tb04500.x. Br J Clin Pharmacol. 1995. PMID: 7547092 Free PMC article. Clinical Trial.

4

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

Blum RA, D'Andrea DT, Florentino BM, Wilton JH, Hilligoss DM, Gardner MJ, Henry EB, Goldstein H, Schentag JJ. Blum RA, et al. Ann Intern Med. 1991 May 1;114(9):755-7. doi: 10.7326/0003-4819-114-9-755. Ann Intern Med. 1991. PMID: 2012358 Clinical Trial. No abstract available.

5

Pharmacokinetics of lomefloxacin in renally compromised patients.

Blum RA, Schultz RW, Schentag JJ. Blum RA, et al. Antimicrob Agents Chemother. 1990 Dec;34(12):2364-8. doi: 10.1128/AAC.34.12.2364. Antimicrob Agents Chemother. 1990. PMID: 2088191 Free PMC article.

6

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers.

Kazierad DJ, Martin DE, Blum RA, Tenero DM, Ilson B, Boike SC, Etheredge R, Jorkasky DK. Kazierad DJ, et al. Among authors: blum ra. Clin Pharmacol Ther. 1997 Oct;62(4):417-25. doi: 10.1016/S0009-9236(97)90120-X. Clin Pharmacol Ther. 1997. PMID: 9357393 Clinical Trial.

7

The effect of renal disease on the disposition of venlafaxine.

Troy SM, Schultz RW, Parker VD, Chiang ST, Blum RA. Troy SM, et al. Among authors: blum ra. Clin Pharmacol Ther. 1994 Jul;56(1):14-21. doi: 10.1038/clpt.1994.95. Clin Pharmacol Ther. 1994. PMID: 8033490

8

Pharmacokinetics of gabapentin in subjects with various degrees of renal function.

Blum RA, Comstock TJ, Sica DA, Schultz RW, Keller E, Reetze P, Bockbrader H, Tuerck D, Busch JA, Reece PA, et al. Blum RA, et al. Clin Pharmacol Ther. 1994 Aug;56(2):154-9. doi: 10.1038/clpt.1994.118. Clin Pharmacol Ther. 1994. PMID: 8062491

9

Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.

Garg V, Blum R, Wilner KD, Jusko WJ. Garg V, et al. J Clin Pharmacol. 1992 Mar;32(3):222-30. doi: 10.1002/j.1552-4604.1992.tb03830.x. J Clin Pharmacol. 1992. PMID: 1564126 Clinical Trial.

10

Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.

Blum RA, Olson SC, Kohli RK, Horvath AM, Sedman AJ, Posvar EL. Blum RA, et al. J Clin Pharmacol. 1990 Oct;30(10):938-42. doi: 10.1002/j.1552-4604.1990.tb03574.x. J Clin Pharmacol. 1990. PMID: 2229454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters